Palladium103QualityChecker
Palladium-103
Utility description: Palladium-103
Palladium-103 Quality Checker — Palladium-103 for Brachytherapy ℹ️ Utility checks critical parameters of Palladium-103: • Radionuclidic purity (≥99.9%) • Palladium-109 impurity (≤0.1%) • Chemical purity (≥99.0%) • Radiochemical purity (≥98.0%) • pH, endotoxins, sterility ⚠️ CRITICAL: Pd-109 impurity >0.1% → beta emission unpredictably alters dose! Sterility failure → high risk of infection during permanent implantation! Usage: Palladium103QualityChecker.exe → demo mode (console output) Palladium103QualityChecker.exe input.csv output.json → evaluate your data Input format: BatchNumber,TotalActivityMBq,RadionuclidicPurityPercent,Palladium109ImpurityPercent,Silver103ImpurityPercent,RadiochemicalPurityPercent,ChemicalPurityPercent,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,ProductType Example (sterility: 0=sterile, 1=contaminated): Pd103-SEED-2026-001,400.0,99.95,0.02,0.01,99.5,99.9,3.0,10.0,0,1,Brachytherapy_Seeds Supported product types: • Brachytherapy_Seeds — permanent implantation for prostate cancer treatment (Low Dose Rate - LDR) • Research_Solution — research purposes — WHY IS THIS NEEDED? Palladium-103 is a key isotope for brachytherapy: • Half-life: 16.99 days • Emission: Characteristic X-rays (20-23 keV) and gamma rays (41 keV) • Used in titanium seeds for permanent placement in the prostate gland • Advantages: Rapid dose fall-off, less shielding required for staff compared to I-125 ⚠️ CRITICAL: • Palladium-109 impurity ≤0.1% — Pd-109 (T½=13.5 h) is a beta emitter. Its presence is unacceptable as beta particles have a short range but create a high local dose on the source surface, potentially leading to necrosis of the urethra or rectum, and distorting the calculated dose. • Chemical purity ≥99.0% — Presence of target material (e.g., Rhodium-103, if produced via Rh-103(p,n)) or other metals can disrupt the coating process on the graphite rod inside the seed, affecting activity uniformity. • Sterility and endotoxins — Critical as seeds are implanted directly into patient tissues. • Radiochemical purity — Determines the form of palladium (usually chloride or metal coating), important for the seed manufacturing process. Key features: • Control of beta-emitting Pd-109 impurity (critical for tissue safety) • Assessment of chemical purity (affects coating quality) • Sterility and endotoxin check for implantable devices • Support for ASTM F2366 standards for Pd-103 seeds Critical parameters: • Radionuclidic purity: ≥99.9% • Palladium-109 impurity: ≤0.1% • Chemical purity: ≥99.0% • Radiochemical purity: ≥98.0% • pH: 1.0–7.0 (depends on form) • Endotoxins: ≤175 EU/vial • Sterility: no microbial growth • Heavy metals: ≤10 ppm 💡 Usage tips: Pd-109 is controlled by gamma spectrometry (search for peaks characteristic of Pd-109/Ag-109m) Chemical purity is determined by ICP-MS or AAS Seed activity is calibrated considering the 17-day half-life In seed production, it is important to control the uniformity of Pd-103 distribution on the carrier ⚠️ Note: Unlike diagnostic radiopharmaceuticals, Pd-103 is used in solid form (seeds). Therefore, quality control often includes not only the precursor solution but also finished product parameters (leak tightness, uniformity). This utility focuses on the radiochemical and radionuclidic parameters of the source material/solution.
input.csv
BatchNumber,TotalActivityMBq,RadionuclidicPurityPercent,Palladium109ImpurityPercent,Silver103ImpurityPercent,RadiochemicalPurityPercent,ChemicalPurityPercent,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,ProductType Pd103-SEED-2026-001,400.0,99.95,0.02,0.01,99.5,99.9,3.0,10.0,0,1,Brachytherapy_Seeds Pd103-SEED-2026-002,380.0,99.80,0.15,0.05,98.0,99.5,3.5,180.0,0,8,Brachytherapy_Seeds Pd103-RES-2026-001,500.0,99.99,0.005,0.001,99.9,99.99,2.0,5.0,0,0.5,Research_Solution
URS & FS — User Requirements and Functional Specification
This document describes the controlled interface and behaviour of Palladium103QualityChecker for Palladium-103.
Domain limits and critical parameters
- ℹ️ Utility checks critical parameters of Palladium-103:
- • Radionuclidic purity (≥99.9%)
- • Palladium-109 impurity (≤0.1%)
- • Chemical purity (≥99.0%)
- • Radiochemical purity (≥98.0%)
- • pH, endotoxins, sterility
- ⚠️ CRITICAL: Pd-109 impurity >0.1% → beta emission unpredictably alters dose!
- Sterility failure → high risk of infection during permanent implantation!
- BatchNumber,TotalActivityMBq,RadionuclidicPurityPercent,Palladium109ImpurityPercent,Silver103ImpurityPercent,RadiochemicalPurityPercent,ChemicalPurityPercent,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,ProductType
- Example (sterility: 0=sterile, 1=contaminated):
- ⚠️ CRITICAL:
- • Chemical purity ≥99.0% — Presence of target material (e.g., Rhodium-103, if produced via Rh-103(p,n)) or other metals can disrupt the coating process on the graphite rod inside the seed, affecting activity uniformity.
- • Sterility and endotoxins — Critical as seeds are implanted directly into patient tissues.
- • Radiochemical purity — Determines the form of palladium (usually chloride or metal coating), important for the seed manufacturing process.
URS — User Requirements Specification
| ID | Requirement | Criticality | Acceptance criterion |
|---|---|---|---|
| URS-001 | The utility shall accept an input.csv file with the exact headers defined in the data contract. | High | The file is processed without manual header editing. |
| URS-002 | The utility shall perform deterministic QC evaluation for Palladium-103 using input values, approved limits and domain rules. | High | Each input row receives a PASS / WARNING / FAIL status. |
| URS-003 | The utility shall validate mandatory fields, data types, numeric ranges, units and pharmaceutical/radiochemical plausibility. | High | Schema and conversion errors are explicitly reported. |
| URS-004 | The utility shall identify critical deviations related to radionuclidic purity, radiochemical purity, free radionuclide, impurities, pH, endotoxins and sterility when such fields are present. | High | A critical deviation causes FAIL or a separate critical finding. |
| URS-005 | The utility shall generate output.json with machine-readable results, source values, warnings and failures. | High | JSON is suitable for LIMS/ELN/MES integration and QA/QC review. |
| URS-006 | The utility shall not use machine learning to decide conformance. | Medium | The result is based on explicit rules, thresholds and input values. |
| URS-007 | The utility shall preserve traceability between batch number, input values, applied rules and final status. | High | The output contains the batch identifier and the list of checked parameters. |
| URS-008 | The documentation shall support IQ/OQ preparation and inspection discussion with FDA/EMA/Roszdravnadzor or local regulators. | Medium | URS & FS, input.csv/output.json contract and test scenarios are supplied with the utility. |
input.csv contract
| # | Field | Type | Sample | Purpose |
|---|---|---|---|---|
| 1 | BatchNumber | string | Pd103-SEED-2026-001 | Batch or lot identifier used for traceability. |
| 2 | TotalActivityMBq | decimal | 400.0 | Radioactivity value used for release, decay or dose-related assessment. |
| 3 | RadionuclidicPurityPercent | string | 99.95 | Radionuclidic purity; a critical radiation-safety and impurity parameter. |
| 4 | Palladium109ImpurityPercent | string | 0.02 | Controlled impurity or residual material. |
| 5 | Silver103ImpurityPercent | string | 0.01 | Controlled impurity or residual material. |
| 6 | RadiochemicalPurityPercent | string | 99.5 | Radiochemical purity; confirms the labelled chemical form and binding quality. |
| 7 | ChemicalPurityPercent | string | 99.9 | Controlled input parameter used by the deterministic QC rules. |
| 8 | pH | decimal | 3.0 | Solution pH; relevant for stability, compatibility and administration. |
| 9 | EndotoxinsEU | decimal | 10.0 | Bacterial endotoxins; critical for parenteral administration. |
| 10 | SterilityTest | flag / boolean | 0 | Sterility result; critical release parameter. |
| 11 | HeavyMetalsPPM | decimal | 1 | Elemental impurity / metal residue parameter. |
| 12 | ProductType | string | Brachytherapy_Seeds | Controlled input parameter used by the deterministic QC rules. |
BatchNumber,TotalActivityMBq,RadionuclidicPurityPercent,Palladium109ImpurityPercent,Silver103ImpurityPercent,RadiochemicalPurityPercent,ChemicalPurityPercent,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,ProductType Pd103-SEED-2026-001,400.0,99.95,0.02,0.01,99.5,99.9,3.0,10.0,0,1,Brachytherapy_Seeds Pd103-SEED-2026-002,380.0,99.80,0.15,0.05,98.0,99.5,3.5,180.0,0,8,Brachytherapy_Seeds Pd103-RES-2026-001,500.0,99.99,0.005,0.001,99.9,99.99,2.0,5.0,0,0.5,Research_Solution
FS — Functional Specification
| ID | Function | Implementation |
|---|---|---|
| FS-001 | CSV import | Read input.csv in UTF-8/CSV-compatible format and validate the header and expected columns. |
| FS-002 | Schema validation | Check mandatory fields and column count; report unknown or missing key fields. |
| FS-003 | Type conversion | Convert numeric, flag and text values; invalid formats are recorded as row-level errors. |
| FS-004 | Domain rule engine | Apply domain rules for Palladium-103, including critical limits from the utility description and approved specification. |
| FS-005 | Status aggregation | Produce final status: FAIL for critical failure, WARNING for non-critical deviation, PASS for conformance. |
| FS-006 | JSON export | Write output.json with detailed checks, source values, warnings, failures and critical findings. |
| FS-007 | Audit support | Keep the result structure suitable for review, deviation investigation, calculation reproduction and IQ/OQ preparation. |
| FS-008 | Integration contract | Support the production scenario: LIMS/ELN/MES creates input.csv, the utility returns output.json, the portal displays description and documentation. |
Example output.json
{
"utilityId": "palladium103-quality-checker",
"api": "Palladium-103",
"overallStatus": "PASS|WARNING|FAIL",
"sourceFile": "input.csv",
"checks": [
{
"parameter": "BatchNumber",
"value": "Pd103-SEED-2026-001",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "TotalActivityMBq",
"value": "400.0",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "RadionuclidicPurityPercent",
"value": "99.95",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Palladium109ImpurityPercent",
"value": "0.02",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Silver103ImpurityPercent",
"value": "0.01",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "RadiochemicalPurityPercent",
"value": "99.5",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "ChemicalPurityPercent",
"value": "99.9",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "pH",
"value": "3.0",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
}
],
"criticalFindings": []
}
OQ/PQ test scenarios
| ID | Scenario | Expected result |
|---|---|---|
| OQ-001 | Valid sample row | PASS or acceptable WARNING according to the rules. |
| OQ-002 | Mandatory column missing | Schema error or FAIL. |
| OQ-003 | Non-numeric value in numeric field | Type-conversion error. |
| OQ-004 | Critical parameter outside limit | FAIL and critical finding. |
| PQ-001 | User real batch/lot | Reviewed result with input.csv and output.json retained. |
QA/QC and change control
- Do not rename columns without updating the validator and test set.
- Retain
input.csv,output.json, executable version and checksum. - Before production use, perform IQ/OQ/PQ or equivalent CSV/CSA verification.
- Critical radiopharmaceutical limits must be verified against the approved specification and local SOPs.
Included in packages
Andrology QC Suite
QC package for andrology: androgens, erectile-dysfunction medicines, BPH/prostate products, fertility and related hormonal checks.
OpenPetRad3: expanded PET/SPECT and radiopharmaceutical QC package
A curated suite for PET/SPECT radiopharmaceuticals, generator and cyclotron radionuclides, labelled compounds, radiochemical purity, breakthrough, sterility and endotoxin control.
OpenRadiology QC Suite
QC package for radiology and diagnostic imaging: radiopharmaceuticals, PET/SPECT, contrast media, iodinated and gadolinium products, plus particle, sterility and endotoxin checks.
OpenRPH organ/system: lymphatic, infection and inflammation
Sentinel node, lymphoscintigraphy, nanocolloid, labelled leukocytes, granulocyte and inflammatory imaging.
OpenRPH organ/system: oncology and theranostics
Tumour imaging, PSMA/FAPI/receptor tracers, immuno-PET, targeted radionuclide therapy and radioembolization.
OpenRPH use case: generators, isotope purity and starting radionuclides
Control of generator eluate, breakthrough, radionuclidic purity, isotope mix, carrier/free radionuclides and starting radionuclides before labeling.
OpenRPH workflow: generators and isotope purity
Generator eluate, breakthrough, radionuclidic purity, isotope mix and starting radionuclides.
OpenRPH workflow: instruments, devices and radiation safety
PET/gamma-camera state, calibration, detector QC, energy window, TOF, shielding and radiation safety.
OpenRPH workflow: product release QC
Assay, purity, sterility, endotoxins, pH, impurities, appearance and batch-release checks.
OpenRPH: combined radiopharmaceutical QC package
RPH combines PetRad, PetRad2 and PetRad3 into one umbrella package for PET/SPECT, therapeutic radionuclides, generators, labelled compounds, decay calculations, sterility, endotoxins and radiochemical/radionuclidic purity.
OpenUrology QC Suite
QC package for urology: BPH, urolithiasis, overactive bladder, urinary-tract infection medicines and supporting antimicrobial QC checks.
Open